Акалабрутиниб-Промомед - analogs
Components: Akalabrutinib |
|||||||||
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
| Prices in pharmacies: — Instructions Акалабрутиниб-Промомед | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Инфира ✘ (incl) Гомеострес ✘ (incl) Бендамустин-ТЛ ✘ (incl) Кветиапин пролонг-алиум ✘ (incl) Мукалтишка ✘ (incl) Matricariya dn ✘ (incl) Boric acid+Nitrofural+[Collagene] ✘ (incl) Лопух, корень - «Фарм-Продукт» ✘ (incl) Энурезан ✘ (incl) Furazidin sodium ✘ (incl) Tremelimumab ✘ (incl) Fosenazide ✘ (incl) Бимикомби Антиглау ЭКО ✘ (incl) Bendazol+Papaverine+Theobromine ✘ (incl) Превенар 20 ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘ✘Analogues of the drug with completely identical active ingredients |
Prices in pharmacies |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 77% — Арбрувия neutral [Ibrutinib]
- 77% — Ибрутиниб Фармасинтез neutral [Ibrutinib]
- 77% — Ибрутиниб-АМЕДАРТ neutral [Ibrutinib]
- 77% — Ибрутиниб-Промомед neutral [Ibrutinib]
- 72% 45-106€ Рибомустин neutral [Bendamustine]
- 68% 1250-1680€ Imbruvica neutral [Ibrutinib]
- 67% 1388.4€ Sprycel neutral [Dasatinib]
- 67% — Dasatinib-nativ neutral [Dasatinib]
- 64% — Дазатиниб-ТЛ neutral [Dasatinib]
- 64% — Дазатиниб-химрар neutral [Dasatinib]
- 64% — Дазатиниб-промомед neutral [Dasatinib]
- 64% — Дазатиниб-Фарм-Синтез neutral [Dasatinib]
- 64% — Дазнибикс neutral [Dasatinib]
- 63% 755-758€ Bosulif neutral [Bosutinib]
- 61% — Мирсониб neutral [Dasatinib]
- 61% 670€ Дазатиниб neutral [Dasatinib]
- 58% — Брукинза neutral [Zanubrutinib]
- 55% 210€ Flidarin Dangerous 🔍 [Fludarabine]
- 55% — Fludarabine-TL Dangerous 🔍 [Fludarabine]
- 54% — Флутотера Dangerous 🔍 [Fludarabine]
- 54% 3068€ Lemtrada neutral [Alemtuzumab]
- 54% — Lanvis neutral [Tioguanine]
- 54% 221€ Fludara Dangerous 🔍 [Fludarabine]
- 54% 363€ Fluguarda Dangerous 🔍 [Fludarabine]
- 54% — Fludarabine phosphate Dangerous 🔍 [Fludarabine]
- 54% 15.2€ Fludarabine-Actavis Dangerous 🔍 [Fludarabine]
- 54% 32.6€ Vero-Fludarabin Dangerous 🔍 [Fludarabine]
- 54% 14.7-21.7€ Fludarabine-Teva Dangerous 🔍 [Fludarabine]
- 54% 201.3€ Fludarabel Dangerous 🔍 [Fludarabine]
- 54% — Fludarabine-Ebewe Dangerous 🔍 [Fludarabine]
- 53% — Сцембликс neutral [Asciminib]
- 51% — Глемихиб Negative 🔍 [Imatinib]
- 51% — Imatinib-Teva Negative 🔍 [Imatinib]
- 51% 271€ Neopax Negative 🔍 [Imatinib]
- 51% — Imatinib-TL Negative 🔍 [Imatinib]
- 51% — Imatinib Grindex Negative 🔍 [Imatinib]
- 51% — Imatinib Dr. Reddy s Negative 🔍 [Imatinib]
- 51% — Imvec Negative 🔍 [Imatinib]
- 51% — Цитонибонко Negative 🔍 [Imatinib]
- 51% 605€ Imatib Negative 🔍 [Imatinib]
- 50% — Mercaptopurine tablets neutral [Mercaptopurine]
- 50% — Lenalidomide-nativ neutral [Lenalidomide]
- 49% 6.7-7.4€ Mercaptopurin neutral [Mercaptopurine]
- 49% — Nilotinib-nativ neutral [Nilotinib]
- 49% 950-1049.7€ Tasigna neutral [Nilotinib]
- 49% — Nilotinib neutral [Nilotinib]
- 49% 108-879€ Atriance neutral [Nelarabine]
- 49% — Nilotinib hydrochloride monohydrate neutral [Nilotinib]
- 49% 2538.7€ Alecensa neutral [Alectinib]
- 49% — Нилотиниб-химрар neutral [Nilotinib]
Learn more about the selection of analogues
▶
- The drug has «Акалабрутиниб-Промомед» 2 full analogs, the cheapest - Калквенс (3947.9€); 51 analog by action, the most similar - Imbruvica (1250-1680€).
- Medical online service has selected the best substitutes for Акалабрутиниб-Промомед based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Акалабрутиниб-Промомед to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.